• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594741)   Today's Articles (655)   Subscriber (49325)
For: Tanaka A, Sakai H, Ishikawa T, Aoki T, Motoyama Y, Fujiwara H, Takasugi H. Rational drug design of the fibrinogen inhibitors FK633 and FR158999. DRUG FUTURE 1998. [DOI: 10.1358/dof.1998.023.03.456545] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Number Cited by Other Article(s)
1
Aoki T, Harada K, Seki J, Tanaka A, Takasugi H, Motoyama Y. FK633: A Potent and Selective Platelet GPIIb/IIIa Antagonist. ACTA ACUST UNITED AC 2006. [DOI: 10.1111/j.1527-3466.1999.tb00010.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
2
Tanaka A, Murata M, Fujiwara H. QSAR study of the peptidic fibrinogen inhibitors FK633, FR158999 and related derivatives, using a novel and useful hydrophobic descriptor (logPmw). Bioorg Med Chem Lett 1998;8:2483-8. [PMID: 9873566 DOI: 10.1016/s0960-894x(98)00405-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA